Drug search by name

Kisqali Femara Co-Pack and Osteoporosis

Result of checking the interaction of drug Kisqali Femara Co-Pack and disease Osteoporosis for safety when used together.

Check result:

Kisqali Femara Co-Pack <> Osteoporosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Use of letrozole tablets may cause decreases in bone mineral density (BMD). Caution should exercise when prescribing this agent to patients with a risk of fractures, such as the elderly and patients with osteoporosis. Consider bone mineral density monitoring in patients treated with letrozole.

Kisqali Femara Co-Pack

Generic Name: letrozole / ribociclib

Brand Name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose

Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose

What is Kisqali Femara Co-Pack?